Drug disposition and clinical practice in neonates: Cross talk between developmental physiology and pharmacology
DOI: 10.1016/j.ijpharm.2012.03.035
Title: Drug disposition and clinical practice in neonates: Cross talk between developmental physiology and pharmacology
Journal Title: International Journal of Pharmaceutics
Volume: 452
Publication Date: 16 August 2013
Start Page: 8
End Page: 13
Published online: online 5 April 2012
ISSN: 0378-5173
Affiliations:

  • a Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium

  • b Laboratory for Pharmacotechnology and Biopharmacy, Department of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Belgium
  • Abstract: Drug dosing in infants should be based on their physiological characteristics and the pharmacokinetic and -dynamic profile of the compound. Since maturational physiological changes are most prominent in infancy, variability is the key feature of clinical pharmacology in infancy: developmental physiology drives developmental pharmacology. This is illustrated by the link between renal physiology and renal Drug clearance and between hepatic physiology and hepatic Drug elimination for some specific compounds. However, the maturational profiles of the individual elimination processes differ substantially at the enzyme and transporter level. This implies that it is important to integrate all ontogeny-related knowledge of the different elimination routes to predict compound specific, phenotypic in vivo observations of infancy.In addition to the introduction of already available in vivo observations to validate mechanistic (estimated to in vivo observations) or physiology based pharmacokinetic (PBPK, developmental physiology related estimated to in vivo observations) models, a simultaneous use of both approaches (mechanistic and PBPK) to search for discrepancies between both approaches may also unveil ‘missing’ links in maturational physiology or clinical pharmacology (e.g. ontogeny renal or hepatic Drug transporters): developmental pharmacology drives developmental pharmacology.
    Accepted: 21 March 2012
    Received: 24 December 2011
    Revised: 10 March 2012
    Keywords: Developmental pharmacology; Maturation; Variability; Covariates; Newborn; Infant
    Tel: +32 16 343850
    Fax: +32 16 343209
    Email: karel.allegaert@uz.kuleuven.ac.be

    Please Share this Paper with friends:
    Comment
    No.
    Comment Content
    User Name
    Date
    Post new Comment
    UserName
    Post to Facebook
    ×
    Search Full Text